{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "exchange": "NCM", "shortName": "Tempest Therapeutics, Inc.", "longName": "Tempest Therapeutics, Inc.", "messageBoardId": "finmb_552715229", "marketState": "REGULAR", "exchangeTimezoneName": "America/New_York", "gmtOffSetMilliseconds": -14400000, "regularMarketChangePercent": -5.963308, "regularMarketPrice": 2.05, "exchangeTimezoneShortName": "EDT", "market": "us_market", "esgPopulated": false, "twoHundredDayAverageChangePercent": 0.08326619, "marketCap": 23752120, "forwardPE": -0.9318181, "priceToBook": 1.1904762, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.5 - Strong Buy", "tradeable": false, "cryptoTradeable": false, "regularMarketPreviousClose": 2.18, "ask": 2.11, "bidSize": 8, "askSize": 8, "fullExchangeName": "NasdaqCM", "financialCurrency": "USD", "regularMarketOpen": 2.21, "averageDailyVolume3Month": 251858, "averageDailyVolume10Day": 134850, "fiftyTwoWeekLowChange": 0.99, "fiftyTwoWeekLowChangePercent": 0.93396235, "fiftyTwoWeekRange": "1.06 - 4.214", "fiftyTwoWeekHighChange": -2.1640003, "fiftyTwoWeekHighChangePercent": -0.5135264, "fiftyTwoWeekLow": 1.06, "fiftyTwoWeekHigh": 4.214, "dividendDate": 1544400000, "earningsTimestamp": 1683749781, "earningsTimestampStart": 1692014400, "earningsTimestampEnd": 1692360000, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -3.21, "epsForward": -2.2, "epsCurrentYear": -2.19, "priceEpsCurrentYear": -0.936073, "sharesOutstanding": 11586400, "bookValue": 1.722, "fiftyDayAverage": 2.03196, "fiftyDayAverageChange": 0.018039942, "fiftyDayAverageChangePercent": 0.008878099, "twoHundredDayAverage": 1.892425, "twoHundredDayAverageChange": 0.15757501, "priceHint": 4, "regularMarketChange": -0.13000011, "regularMarketTime": 1684260968, "regularMarketDayHigh": 2.22, "regularMarketDayRange": "2.04 - 2.22", "regularMarketDayLow": 2.04, "regularMarketVolume": 38617, "bid": 2.04, "firstTradeDateMilliseconds": 1352730600000, "displayName": "Tempest Therapeutics", "symbol": "TPST"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "2000 Sierra Point Parkway", "address2": "Suite 400", "city": "Brisbane", "state": "CA", "zip": "94005", "country": "United States", "phone": "415 798 8589", "website": "https://www.tempesttx.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Tempest Therapeutics, Inc., a clinical-stage oncology company, develops small molecule therapeutics that combine both tumor-targeted and immune-mediated mechanisms to treat various tumors. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, which is in a Phase 1 trial to treat solid tumors; and TPST-1120, a selective antagonist of peroxisome proliferator-activated receptor alpha that is in a Phase 1 trial for the treatment of solid tumors. It also develops TREX-1, a key cellular enzyme that regulates the innate immune response in tumors. Tempest Therapeutics, Inc. is headquartered in Brisbane, California.", "fullTimeEmployees": 19, "companyOfficers": [{"maxAge": 1, "name": "Mr. Stephen R. Brady J.D., LLM", "age": 52, "title": "CEO & Director", "yearBorn": 1970, "fiscalYear": 2021, "totalPay": {"raw": 665396, "fmt": "665.4k", "longFmt": "665,396"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Thomas W. Dubensky Jr., Ph.D.", "age": 64, "title": "Pres & Director", "yearBorn": 1958, "fiscalYear": 2021, "totalPay": {"raw": 938073, "fmt": "938.07k", "longFmt": "938,073"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Samuel  Whiting M.D., Ph.D.", "title": "Exec. VP & Chief Medical Officer", "fiscalYear": 2021, "totalPay": {"raw": 540000, "fmt": "540k", "longFmt": "540,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Nicholas  Maestas", "age": 42, "title": "VP of Strategy & Fin. and Sec.", "yearBorn": 1980, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Justin  Trojanowski", "age": 34, "title": "Corp. Controller, Treasurer & Principal Accounting Officer", "yearBorn": 1988, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Sharon  Sakai Ph.D., RAC", "title": "Head of Regulatory & Quality", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Anne  Moon", "title": "Sr. VP and Head of Project Team Leadership, Project Management &  Portfolio Management", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}